CIBC Asset Management Inc Acquires 1,362 Shares of HCA Healthcare, Inc. (NYSE:HCA)

CIBC Asset Management Inc lifted its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 29,427 shares of the company’s stock after acquiring an additional 1,362 shares during the period. CIBC Asset Management Inc’s holdings in HCA Healthcare were worth $11,960,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in HCA. Bangor Savings Bank raised its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $28,000. GPS Wealth Strategies Group LLC grew its stake in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare in the 2nd quarter worth approximately $33,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $342.96 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The business’s 50-day simple moving average is $385.11 and its two-hundred day simple moving average is $357.58. The stock has a market cap of $86.87 billion, a PE ratio of 15.40, a P/E/G ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a 52 week low of $238.82 and a 52 week high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. HCA Healthcare’s payout ratio is 11.85%.

Insider Activity

In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,155 shares of company stock worth $5,608,990 over the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HCA. Royal Bank of Canada upped their price target on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. KeyCorp cut their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. TD Cowen cut their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Finally, Leerink Partners raised their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $385.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.